Bioinformatics · 2012 · 141 citations · 9 references
PharmacyBioinformaticsMedicinal ChemistryDrug DesignDrug DiscoveryStructural BioinformaticsDrug DatabasesFragment-based Drug DesignFragment-based Lead DiscoveryStructure-based RepurposingVirtual ScreeningLibrary Collections
Abstract Motivation: In the drug discovery field, new uses for old drugs, selective optimization of side activities and fragment-based drug design (FBDD) have proved to be successful alternatives to high-throughput screening. e-Drug3D is a database of 3D chemical structures of drugs that provides several collections of ready-to-screen SD files of drugs and commercial drug fragments. They are natural inputs in studies dedicated to drug repurposing and FBDD. Availability: e-Drug3D collections are freely available at http://chemoinfo.ipmc.cnrs.fr/e-drug3d.html either for download or for direct in silico web-based screenings. Contact: douguet@ipmc.cnrs.fr Supplementary information: Supplementary data are available at Bioinformatics online.
9
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton, Louisa J. Bellis, A. Patrícia Bento et al. · Nucleic Acids Research · 2011 · 4.5K citations · Full text
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox, Vivian Law, Timothy Jewison et al. · Nucleic Acids Research · 2010 · 1.9K citations · Full text
Drug Target Identification Using Side-Effect Similarity
Mónica Campillos, Michael Kuhn, Anne‐Claude Gavin et al. · Science · 2008 · 1.2K citations
Fragment-Based Lead Discovery Using X-ray Crystallography
Michael J. Hartshorn, Christopher W. Murray, Anne Cleasby et al. · Journal of Medicinal Chemistry · 2004 · 423 citations